Choice International Ltd. moves to reshape its capital structure

The filing does not specify the reserve-by-reserve mix. It permits capitalization from the Securities Premium Account and/or other free reserves, but does not identify whether General Reserve, Retained Earnings, or Securities Premium will bear the full amount. The 1:1 bonus requires ₹222.78 Cr of capitalization, against audited eligible free reserves/securities premium of ₹745.88 Cr as of 31 March 2026 ^[1].

Reserve impact

The residual of ₹523.11 Cr is calculated as ₹745.88 Cr less ₹222.78 Cr. However, it should be treated as the remaining aggregate pool identified by the company, not as confirmed retained earnings or General Reserve, because the filing does not provide the individual reserve balances or the precise debit allocation.

Economically, the transaction is a reclassification within shareholders’ equity, increasing paid-up equity capital from ₹222.78 Cr to ₹445.55 Cr while reducing the eligible free-reserve/securities-premium pool by ₹222.78 Cr ^[1]. It does not, on the disclosed terms, create an operating cash outflow; the trade-off is that roughly 29.8% of the disclosed capitalization pool becomes unavailable in reserve form for subsequent capital-allocation purposes. The bonus proposal remained subject to shareholder approval in the board-meeting disclosure ^[2].

The proposed authorized share capital would rise to ₹447.80 Cr, divided into 44.78 Cr equity shares of ₹10 each, from ₹225 Cr currently. The increase remains subject to shareholder approval. ^[2]

The 1:1 bonus would take paid-up equity capital to ₹445.55 Cr, representing 44.5553 Cr shares of ₹10 each, from ₹222.78 Cr pre-bonus. ^[1]

Implication: the enlarged ceiling accommodates the entire post-bonus paid-up base, leaving derived nominal headroom of approximately ₹2.25 Cr, equivalent to 22.47 lakh additional ₹10 shares. Thus, the proposed authorized capital is set only marginally above the post-bonus paid-up equity base.

The 1:1 bonus is a capitalisation event, not a new capital infusion. It doubles Choice International’s paid-up equity share capital from ₹222.77 Cr to ₹445.55 Cr by issuing 22,27,76,500 shares, funded from securities premium and free reserves—not from fresh cash raised from shareholders. ^[1]

Historical frequency

The historical frequency of Choice International’s bonus issues or other capital distributions could not be confirmed from the cited material. Therefore, the 1:1 ratio can be described as a sizeable one-time doubling of the share count, but not as unusually frequent or infrequent relative to a verified company history.

The action is also subject to shareholder approval, with the record date still to be announced. ^[2]

Effect on capital and regulatory ratios

The important distinction is between paid-up share capital and total equity/net worth:

• Standalone equity share capital was ₹222.78 Cr in Q1 FY27, while standalone total equity was ₹1,035.8 Cr. ^{[3] [4]}
• Because the bonus is funded by transferring ₹222.77 Cr from reserves or securities premium into paid-up capital, it should, mechanically, reclassify shareholders’ funds rather than increase total equity. That means the company’s net worth does not rise merely because the paid-up capital doubles.
• Consequently, the bonus should not by itself improve a financial-services subsidiary’s capital adequacy ratio. Regulatory capital adequacy is generally assessed at the regulated-entity level using eligible regulatory capital relative to risk-weighted assets, not by looking only at the parent’s nominal paid-up share capital.
• Any effect would depend on whether the bonus is implemented within the regulated entity, whether the relevant reserves qualify as regulatory capital, and whether the regulator permits the resulting capital composition. Those entity-level capital adequacy ratios and a pro-forma calculation are not reported in the cited sources.

Analytical conclusion: the transaction changes the form and number of equity shares, but not necessarily the amount of deployable regulatory capital. It may improve the parent’s paid-up-capital optics and share liquidity, while the effect on CRAR or other regulatory ratios remains unproven without subsidiary-level regulatory capital and risk-weighted-asset data.